News and Announcements

How RNA Editing May Promote Tumor Growth

March 21st, 2016in Publications

Thursday, March 17 2016 | Source: BUSM A new study provides insight on the potential role played by RNA (ribonucleic acid) editing in cancer. The findings, which appear online in the journal Scientific Reports, may further our understanding of an emerging mechanism implicated in tumor initiation and progression, and may thus lead to... More

Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier

April 30th, 2015in Press Release

Press: April 16, 2015 | Veracyte South San Francisco, Calif. --- April 16, 2015 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta™ Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The... More

Behind the Vapor – Chasing the facts behind e-cigarette health risks

October 22nd, 2014in Press Release

Press: October 20, 2014; written by Sara Rimer | BU Research  With the public health community sharply divided over the potential benefit and harm of the popular device—and with conclusive scientific evidence in short supply—the World Health Organization (WHO) released a report in August 2014 that raised serious questions about the health impact... More

Researchers will study relation of environment to breast cancer

October 17th, 2014in Press Release

Press: October 16th 2014, written by Todd Feathers | Boston Globe Five eminent Boston researchers will officially join forces Thursday to tackle one of the most perplexing questions about breast cancer: Why do so many people with no family history of the disease get it? The researchers will examine whether common man-made... More

Veracyte to Acquire Allegro Diagnostics: Plans to Launch Lung Cancer Test

September 9th, 2014in Press Release

Press release: September 4th 2014  SOUTH SAN FRANCISCO, Calif., Sept. 4, 2014 /PRNewswire/ -- Veracyte, a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to acquire Allegro Diagnostics Corp. based in Maynard, Mass., for $21.0 million, comprised of $7.8 million in cash and $13.2 million in Veracyte... More

New way to determine cancer risk of chemicals found

August 25th, 2014in Press Release, Publications

Press Release from July 24th 2014 A new study has shown that it is possible to predict long-term cancer risk from a chemical exposure by measuring the short-term effects of that same exposure. The findings, which currently appear in the journal PLOS ONE, will make it possible to develop simpler and cheaper... More

Never Smoker Lung Cancer

January 24th, 2013in Press Release

Press Release : BU Today January 22 2013 Never Smoked. Lived Right. Died of Lung Cancer. By Rich Barlow Avrum Spira’s aunt died of lung cancer almost 20 years ago. She was a nonsmoking exercise buff in her 40s who hadn’t been exposed to any known toxins; she worked in a government office, More